Arkolith/Insider Trading/CTNM/Form 4

Lorrain Daniel S.

Chief Scientific OfficerContineum Therapeutics, Inc. (CTNM) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$130K
Net Open-Market Flow
-$130K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2026Sell(S)4K$16.01$61K156K
Feb 25, 2026Option exercise(M)4K$1.01$4K160K
Feb 24, 2026Option exercise(M)4K$1.01$4K160K
Feb 24, 2026Sell(S)4K$16.03$69K156K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 25, 2026Option exercise(M)4K—$067K
Feb 24, 2026Option exercise(M)4K—$071K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-005889) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Contineum Therapeutics, Inc.

Build

Ask your agent about CTNM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001437749-26-005889"
Ask your agent
Use Arkolith to summarize insider buying and selling at Contineum Therapeutics, Inc.
over the last 90 days and cite the filings.